The global pneumococcal vaccine market, valued at $8.15 billion in 2025, shows steady growth driven by increasing geriatric populations and rising vaccination awareness. Learn about market trends, key players (Pfizer, GSK, MSD), and future projections in this comprehensive analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.